TC
ACH

Trilogy Capital’s Accendra Health ACH Stock Holding History

Trilogy Capital’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,983
Closed -$242K – 281
2023
Q3 		$242K Sell
14,983
-1,510
-9% -$26.8K 0.02% 236
2023
Q2 		$315K Sell
16,493
-113
-0.7% -$2.02K 0.02% 222
2023
Q1 		$242K Buy
+16,606
New +$297K 0.02% 232
2019
Q1 		– Sell
-16,126
Closed -$102K – 153
2018
Q4 		$102K Sell
16,126
-2,329
-13% -$24.2K 0.01% 128
2018
Q3 		$305K Sell
18,455
-2,502
-12% -$42.5K 0.04% 113
2018
Q2 		$350K Sell
20,957
-2,791
-12% -$45.2K 0.05% 94
2018
Q1 		$369K Buy
+23,748
New +$423K 0.05% 90

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trilogy Capital's ACH Position: Q4 2023 in Review

Trilogy Capital sold out of Accendra Health (ACH) in Q4 2023, closing a stake of 14,983 shares — an estimated $242K sold.

Trilogy Capital first reported a position in ACH in Q1 2018 and held it in 7 quarters. The position peaked at $369K in Q1 2018. 227 funds tracked by Wall St. Rank hold ACH as of Q4 2023.

  • Trilogy Capital reported no remaining Accendra Health position as of Q4 2023 after selling out during the quarter.
  • Trilogy Capital sold 14,983 Accendra Health shares in Q4 2023, an estimated $242K.
  • Trilogy Capital first reported a position in Accendra Health in Q1 2018 and held it in 7 quarters.
  • Trilogy Capital's Accendra Health position peaked at $369K in Q1 2018.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q4 2023.

Based on Trilogy Capital's 13F filing for Q4 2023, filed 12 Jan 2024.